Amlodipine Plus Botulinum Toxin for Focal Dystonia

Completed · Phase 2

Conditions studied: Focal Dystonia

In brief

Objective: To determine if the calcium channel blockers, amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia. Study Population: 20 patients with cervical dystonia Design: Double-bind, placebo-controlled clinical trail. Outcome measures: For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia scale, NINDS subjective patient rating scale), and hand grip strength. For healthy volunteers: Amplitude of EDB MEP.

Key facts

Study ID
NCT00015457
Run by
National Institute of Neurological Disorders and Stroke (NINDS)
People needed
16
Starts
2001-04-01
Last updated by the study team
2013-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.